Transdermis(TM) Scar Therapy Now Available Nationwide
FAYETTEVILLE, North Carolina -- TransdermisTM Scar Therapy (www.transdermis.com), a new and novel approach for topical scar modification, announces national distribution. Transdermis is available nationwide at CVS/Pharmacy and Rite Aid.
Developed in conjunction with Jerome D. Chao, MD, a board certified Plastic Surgeon from NY, TransdermisTM Scar Therapy offers a unique alternative to current scar creams and silicone based liquid solutions. TransdermisTM Scar Therapy targets the source of scar formation with revolutionary patent pending refined emu oil which is rich in Omega 3 and 6 fatty acids. The natural anti-inflammatory properties of this all natural ingredient, combined with an enhanced processing technology, has created an effective and well tolerated topical scar serum unlike anything on the market today.
Physicians have been expressing concerns relative to the efficacy of current scar therapies for years, and according to Dr. Chao, TransdermisTM Scar Therapy provides a solution to the problem with scars, "I've tested most of the topical scar products to date, and have not found anything as effective as Transdermis(TM) Scar Therapy. It is well tolerated by the skin, enhances patients compliance, and it works! After assisting in the formulation of the product, I was so impressed with the results of my pilot study; I submitted a University based study to validate my findings. Patients love the way it feels and of course the way it works in reducing the appearance of scars. Transdermis(TM) Scar Therapy is rapidly becoming the standard of care for physicians concerned with topical scar management."
NFI Consumer Products manufactures, markets, and exclusively distributes Transdermis(TM) Scar Therapy. "We are excited and committed to offer such a timely product that has real science behind it, and honored to have physicians like Dr. Chao and others endorsing its benefits," says Larry Chriscoe, President and CEO of NFI. Brand Manager Chris Doster concludes, "We feel Transdermis(TM) Scar Therapy is positioned to become a leader in scar care market based on the incredible feedback from physicians around the country."
Contacts
NFI Consumer Products
Mark Holman, Public Relations, 910-860-9740
press@nficorporate.com
Developed in conjunction with Jerome D. Chao, MD, a board certified Plastic Surgeon from NY, TransdermisTM Scar Therapy offers a unique alternative to current scar creams and silicone based liquid solutions. TransdermisTM Scar Therapy targets the source of scar formation with revolutionary patent pending refined emu oil which is rich in Omega 3 and 6 fatty acids. The natural anti-inflammatory properties of this all natural ingredient, combined with an enhanced processing technology, has created an effective and well tolerated topical scar serum unlike anything on the market today.
Physicians have been expressing concerns relative to the efficacy of current scar therapies for years, and according to Dr. Chao, TransdermisTM Scar Therapy provides a solution to the problem with scars, "I've tested most of the topical scar products to date, and have not found anything as effective as Transdermis(TM) Scar Therapy. It is well tolerated by the skin, enhances patients compliance, and it works! After assisting in the formulation of the product, I was so impressed with the results of my pilot study; I submitted a University based study to validate my findings. Patients love the way it feels and of course the way it works in reducing the appearance of scars. Transdermis(TM) Scar Therapy is rapidly becoming the standard of care for physicians concerned with topical scar management."
NFI Consumer Products manufactures, markets, and exclusively distributes Transdermis(TM) Scar Therapy. "We are excited and committed to offer such a timely product that has real science behind it, and honored to have physicians like Dr. Chao and others endorsing its benefits," says Larry Chriscoe, President and CEO of NFI. Brand Manager Chris Doster concludes, "We feel Transdermis(TM) Scar Therapy is positioned to become a leader in scar care market based on the incredible feedback from physicians around the country."
Contacts
NFI Consumer Products
Mark Holman, Public Relations, 910-860-9740
press@nficorporate.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.